Las Vegas, NV, Oct. 19, 2017 -- Vapetek, Inc. (OTC: VPTK), a technology company with a focus on developing, marketing, and selling electronic cigarette products, including e-liquids, high-capacity rechargeable batteries, and vaporizing devices, recently met the strict October 12th deadline for e-liquid products to be registered with the US Food and Drug Administration (FDA). Additionally, the company has successfully launched its Rock Kandi e-liquid lineup through several new key distribution channels, and is actively seeking more.
Earlier this year, the FDA extended a deadline for all e-liquid manufacturers to register their products before October 12, 2017. Vapetek registered its e-liquid products with the FDA through the PMTA process, and received the necessary regulatory approvals to ensure that the company’s products remain legal for sale and consumption for years to come. These approvals substantially reduce short-term regulatory risk, and the experience gained will help the company move new products through the approval process much more quickly in the future.
As the company’s innovative Rock Kandi e-liquids gain traction, it has become increasingly important to develop a strong distribution network. In doing so, the company has successfully launched its products for sale on three very successful and popular e-commerce vaping websites: ejuice.co, eliquid.com, and westcoastvapesupply.com
“Rock Kandi has been a consistent fan favorite, having won praise by industry insiders around the globe,” stated Andy Ibrahim, Vapetek's CEO of North America. He added, "The repeated success of the product supports our marketing strategy of introducing new brands across North America, Europe, Asia and other parts of the world.”
The company encourages anyone interested in distributing Rock Kandi e-liquid products to inquire about wholesale ordering by calling (800) 811-6770.
About Vapetek, Inc.
Vapetek, Inc. (OTC: VPTK) is a vaporizing technology and e-liquid company that develops vaporizing devices, e-cigarettes, e-liquids, rechargeable batteries, and atomizers. The company develops high-quality products, which are USP-grade and pass rigorous inspection. With an estimated 28% of the U.S. population actively smoking cigarettes, Vapetek hopes to provide a safer nicotine delivery system to millions of people.
Forward Looking Statements
This release may contain forward-looking statements, including, without limitation, statements containing the words "believes", "anticipates", "expects", "intends", "plans", "seeks", "estimates", "may", "will", "could", "stands to" and "continues", as well as similar expressions. Such forward-looking statements may involve known and unknown risks, uncertainties and other factors which might cause the actual results, financial condition, performance or achievements of Vapetek, Inc., or industry results, to be materially different from any historic or future results, financial conditions, performance or achievements expressed or implied by such forward-looking statements. Given these uncertainties, the reader is advised not to place any undue reliance on such forward-looking statements. These forward-looking statements speak only as of the date of publication of this document. Vapetek, Inc. expressly disclaims any obligation to update any such forward-looking statements in this document to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based, unless required by law or regulation.
Investor Relations VPTK [email protected] 813-500-7332


Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 



